Author

Q. Zuo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

J. TangiD· 2 shared Z. Madak-Erdogan· 2 shared A. E. Dean· 1 shared A. N. Mogol· 1 shared A. S. Casiano· 1 shared A. S. Raghavendra· 1 shared B. H. Park· 1 shared B. Pitard· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. TangORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge

S. Sun, E. Li, G. Zhao, J. Tang, Q. Zuo, L. Cai, C. Xu, C. Sui, Y. Ou, C. Liu, H. Li, Y. Ding, C. Li, D. Lu, W. Zhang, , S. Guan

This study shows that peptide-poloxamine-DNA nanoparticles provide complete protection against lethal SARS-CoV-2 challenge through robust mucosal immunity.

bioRxiv · May 29, 2022Immunology

Targeting metabolic adaptations in the breast cancer liver metastatic niche using dietary approaches to improve endocrine therapy efficacy

Q. Zuo, A. N. Mogol, Y.-J. Liu, A. S. Casiano, C. Chien, J. Drnevich, O. B. Imir, E. Kulkoyluoglu-Cotul, N. H. Park, D. J. Shapiro, B. H. Park, Y. Ziegler, B. S. Katzenellenbogen, E. Aranda, J. D. O'Neill, , Z. Madak-Erdogan

This study identifies a mechanism of endocrine resistance in liver metastases of ER+ breast cancer and shows that a fasting-mimicking diet enhances the efficacy of fulvestrant treatment.

bioRxiv · Sep 7, 2021Cancer Biology

Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females.

M. E. Patton, S. Kelekar, L. J. Taylor, A. E. Dean, Q. Zuo, R. N. Thakare, S. H. Lee, E. Gentry, M. Panitchpakdi, P. Dorrestein, Y. Alnouti, Z. Madak-Erdogan, J.-S. Lee, M. J. Finegold, S. Anakk

This study identifies sex-specific bile acid metabolism differences that protect female livers from liver cancer and suggests targeting bile acid excretion as a therapeutic strategy.

bioRxiv · Jun 25, 2020Cancer Biology

Bcl6 Preserves the Suppressive Function of Regulatory T Cells during Tumorigenesis

Y. Li, Z. Wang, H. Lin, L. Wang, X. Chen, Q. Liu, Q. Zuo, J. Hu, H. Wang, J. Guo, L. Xie, J. Tang, Z. Li, L. Hu, L. Ye, , L. Xu

This study shows that Bcl6 deletion in Treg cells reduces tumor growth by impairing their suppressive function, and increased Bcl6 expression is linked to poor cancer outcomes.

Frontiers in Immunology · May 12, 2020Peer-reviewedImmunology